FDA Inspection 1302094 — Southern Blood Services Inc

Southern Blood Services Inc — FEI 3002597075

The FDA completed an inspection of Southern Blood Services Inc on February 3, 2026 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 3, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Nashville, TN (United States)